Cellular Goods: A unique and innovative approach to CBD focused on delivering premium consumer produ

  • Cellular Goods signs supply agreement ahead of autumn launch of skincare range
  • Aiming high: how to make investment choices in the cannabis world
  • Cellular Goods ‘delighted UK has embraced cannabinoids and listing’ as company makes IPO debut
Cellular Goods PLC -

Quick facts: Cellular Goods PLC


View company profile

We are a UK-based premium consumer brand serving the skincare and sports recovery markets. Our products are formulated with lab-made, approved and high-quality cannabinoids. Harmonising nature with science, our formulations work in symbiosis with the body. Because our cannabinoids are biosynthetic they are always pesticide-free, legal, not animal-tested and more sustainable than those derived from plants. The company is headquartered in London and listed on the main market of the London Stock Exchange. Please visit www.cellulargoods.co

10 Jun 2021

() signed a multi-year supply agreement for cannabigerol (CBG) with Toronto-listed Willow Biosciences.

Willow will supply Cellular Goods with its proprietary, ultra-pure, biosynthetically produced, cannabigerol to be used in Cellular Goods’ premium cannabinoid-based skincare products which will be launched in the autumn of 2021.

“Successful products start with the best ingredients and being able to source consistent, highly pure cannabinoids via cellular agriculture from a trusted provider like Willow is essential to our business. CBG is the most promising cannabinoid for skincare applications and we believe it will become a must-have upgrade to people’s daily routines,” said Alexis Abraham, the chief executive officer of Cellular Goods.

“Cellular Goods will be the first to bring a range to market in the UK built on our core principles of delivering efficacy-led and research-backed consumer cannabinoid products,” Abraham added.

Read more

25 May 2021

(), the maker of lab-made cannabinoid products backed by David Beckham, said it is on track to roll out its first consumer product range in Autumn this year followed by a ‘movement’ product range for the after-sport recovery market next Spring.

In an outlook statement accompanying its half-year results, the company said it is looking to the future “with confidence” amid growing public acceptance and scientific validation of the benefits of cannabinoids.

Read more

12 Apr 2021

Cellular Goods (), the David Beckham-backed maker of synthetic-CBD based consumer products, has made five appointments to strengthen its management team and develop its skin and pet care ranges.

Istok Nahtigal joins as Head of Process and Applied Sciences to focus on Cellular Goods’ cannabinoid supply chain and will be responsible for optimising the relationships with its manufacturing partners.

Read more

18 Mar 2021

Picking stocks in the cannabis space can be a daunting task, but what once used to be a very ‘out there’ sector is now whetting the appetite of investors.

It all started in 2018, when Canada legalised recreational use, but the UK is becoming an increasingly fertile ground for the sector after the FCA allowed medicinal cannabis companies to list in London last September.

Read more

26 Feb 2021

‘s () Alexis Abraham talks to Proactive London’s Katie Pilbeam about their first day of trading on the London Stock Exchange.

Abraham says he is ‘delighted the UK has embraced cannabinoids and our listing with such enthusiasm’.

The provider of premium consumer products based on biosynthetic cannabinoids, which are compounds produced in the lab from cannabis plants, completed its initial public offering (IPO) after a GBP13mln fundraising.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash…


Market Report: FTSE fights off inflation woes as traders await US inflation…

The Market Report with Katie Pilbeam.

FTSE 100 opened higher as the G7 summit kicks off and investors waited for inflation data from the Europe and the US. London’s blue-chip index rose by 21 to 7,102.

BT has a new largest shareholder. French telecoms group Altice has taken a 12.1% stake…

5 hours, 16 minutes ago

5 min read


Please enter your comment!
Please enter your name here